The Kaplan Meyer curves for the estimation of the incidence of HCC by non-SVR patients with post-treatment ALT <40 U/L, classified by HOMA-IR using the 3.0 cut-off level, are shown in Fig. 2a. The gene discussed is GPT; the disease is hepatocellular carcinoma.